Wilma L. Lingle

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

Edward H. Romond, Edith A. Perez, John Bryant et al. · New England Journal of Medicine · 2005 · 5.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Benign Breast Disease and the Risk of Breast Cancer

Lynn C. Hartmann, Thomas A. Sellers, Marlene H. Frost et al. · New England Journal of Medicine · 2005 · 942 citations · Full text

Medicine, Oncology, Pathology +17

Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes

Matthew P. Goetz, James M. Rae, Vera J. Suman et al. · Journal of Clinical Oncology · 2005 · 786 citations · Full text

Medicine, Oncology, Pharmacology +16

FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt

Huadong Pei, Liang Li, Brooke L. Fridley et al. · Cancer Cell · 2009 · 732 citations · Full text

Medicine, Cancer Biology, Oncology +14

Centrosome amplification drives chromosomal instability in breast tumor development

Wilma L. Lingle, Susan L. Barrett, Vivian Negron et al. · Proceedings of the National Academy of Sciences · 2002 · 571 citations · Full text

Life Sciences, Genetics, Oncology +17